Clareon™ CNA0T0 (REF CNA0T0.290)Recalls & reported problems
Alcon Laboratories, Inc. · Clareon Aspheric Hydrophobic Acrylic IOL with the AutonoMeAutomated Pre-loaded Delivery System · Class 3 · Implant
All models of Clareon (1142)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 6
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 00380652396516), received between Jan 31, 2024 and Apr 3, 2026 — classified as 3 injuries, 3 malfunctions.
The most frequently reported specific device problem is “Device Damaged by Another Device” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Device Damaged by Another Device1
- Device Difficult to Setup or Prepare1
- Failure to Unfold or Unwrap1
- Inaccurate Delivery1
Patient problems
- Insufficient Information2
- No Clinical Signs, Symptoms or Conditions2
- Blurred Vision1
- Corneal Edema1
- Eye Injury1
- Visual Impairment1
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
MalfunctionApr 3, 2026Inaccurate Delivery
A NON-HEALTHCARE PROFESSIONAL REPORTED THAT DURING THE INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE THE LENS WAS CAUGHT IN THE INCISION. ADDITIONAL INFORMATION RECEIVED AND STATED THAT THE SURGEON DID NOT REMEMBER THIS SIZE HAS A LARGER NOZZLE AND NEEDS A WIDER INCISIONS.
Patient problems: Insufficient Information
MAUDE report 24774738 ↗MalfunctionOct 18, 2025Device Difficult to Setup or Prepare; Device Difficult to Setup or Prepare
A FACILITY REPRESENTATIVE REPORTED THAT DURING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, LEADING HAPTIC FLIPPED AND WOULDN'T LET THE SURGEON STOP INJECTING. LENS WAS INJECTED HALFWAY BY THE SURGEON BEFORE REMOVAL. THE LENS WAS REMOVED DURING INITIAL PROCEDURE. THE PROCEDURE WAS COMPLETED ON THE SAME DAY. THERE WAS NO HARM TO THE PATIENT. ADDITIONAL INFORMATION WAS REQUESTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23332085 ↗MalfunctionJul 14, 2025Failure to Unfold or Unwrap; Failure to Unfold or Unwrap
ADDITIONAL INFORMATION RECEIVED STATING TRAILING HAPTIC STUCK TO OPTIC. LENS WAS LEFT IMPLANTED. THERE WAS NO PATIENT HARM.
Patient problems: Insufficient Information; No Clinical Signs, Symptoms or Conditions
MAUDE report 22496130 ↗InjuryNov 6, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A FACILITY REPRESENTATIVE REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT HAD POOR VISION. THE IOL WAS EXCHANGED FOR UNSPECIFIED MONOFOCAL LENS. CLINICAL REASON FOR EXPLANT MENTIONED AS MISSED TARGET. ADDITIONAL INFORMATION HAS BEEN REQUESTED, RECEIVED AND STATED THAT THE IOL WAS EXCHANGED FOR THE SAME LENS MODEL BUT NINE DIOPTERS LESS POWER. THERE WAS NO PATIENT HARM.
Patient problems: Visual Impairment
MAUDE report 20622798 ↗InjuryOct 30, 2024Device Damaged by Another Device; Device Damaged by Another Device
A HEALTHCARE PROFESSIONAL REPORTED THAT DURING AN INTRAOCULAR LENS (IOL) IMPLANTATION PROCEDURE, IMPLANTATION FAILURE OCCURRED THOUGH INCISION ENLARGEMENT HAS BEEN DONE. THE LENS WAS SUBSEQUENTLY LOADED IN NON-PRELOADED CARTRIDGE. WHEN THE IMPLANT WAS DEPLOYED IN THE EYE, HALF OF THE UPPER HAPTIC WAS BROKEN AND REMOVED. THE IMPLANT WAS POSITIONED NORMALLY, BUT IT WAS DECIDED TO LEAVE IT IN PLACE SO AS NOT TO BE DELETERIOUS IF THE IMPLANT WAS REMOVED AS THE LENS DIOPTER WAS HIGH. ADDITIONAL INFORMATION WAS RECEIVED STATING AS PER THE PATIENT'S DIOPTER AND EYE TYPE (SMALL WITH CORNEAL DEGENERATION), SURGEON DECIDED TO LEAVE IT IN, AS LENS WAS STABLE. ON POST-OP DAY 7, THE IMPLANT WAS CENTERED.
Patient problems: Eye Injury
MAUDE report 20570641 ↗InjuryJan 31, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A NON HEALTHCARE PROFESSIONAL REPORTED THAT, AFTER INTRAOCULAR LENS EXPLANATION AND REPLACEMENT SURGERY, THE PATIENT EXPERIENCED BLURRY VISION. THE SURGEON REPORTED THAT, THE POST OPERATIVE SWELLING CONTRIBUTED TO THE BLURRY VISION AND THE BLURRY VISION WILL SUBSIDE OR RESOLVE ONCE THE SWELLING IS HEALED.
Patient problems: Blurred Vision; Corneal Edema
MAUDE report 18612061 ↗
Other Lens, multifocal intraocular devices
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular144 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular1 recall66 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular113 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular112 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular110 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular107 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular104 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular93 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page